Science Advances
Prediction of mild cognitive impairment progression using time-sensitive multimodal biomarkers
Cohort study of 102 peopleBiomarkers
5.9 years
- Mild cognitive impairment
- Entorhinal tau
- Gamma activity
- MEG alpha power
- Neocortical amyloid burden
- Humans
The paper
Montreal Neurological Institute and Hospital
Science Advances, 12 Aug 2026



